Dual benefit of supplementary oral 5‐aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model
暂无分享,去创建一个
S. Anai | M. Miyake | N. Tanaka | Y. Nakai | K. Torimoto | K. Aoki | K. Fujimoto | S. Ohnishi | Takeshi Inoue | T. Fujii | T. Owari | Y. Itami | S. Hori | Y. Morizawa | Kota Iida | D. Gotoh | Hiroo Takahashi | Kenta Ohnishi | Tomomi Fujii